InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.32
(
0.35%
)
Bitcoin
62,354.54
(
-1.27%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4127
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: DewDiligence post# 7084

Saturday, 01/19/2008 2:09:42 PM

Saturday, January 19, 2008 2:09:42 PM

Post# of 19309
One of the points I was making was that they were trying to drive ATIIII to very high levels for 4 days then analzying the effects on clotting a very short time afterwards. That is quite different from what GTCB/LEO are trying, to bring ATIII to normal levels in patients where ATIII had dropped to very low levels, maintaining ATIII at this more physiological levels during the entire interval of care. GTCB/Leo will then monitor survival (and presumably DIC) at multiple intervals, which I believe begins at the 28 day survival.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up